Ketamine for OCD
Find clinics offering ketamine therapy for obsessive-compulsive disorder.
Reviewed for clinical accuracy against peer-reviewed literature and FDA guidelines · Last reviewed March 2026
🔬 Ketamine Therapy for OCD: What You Need to Know
Obsessive-compulsive disorder (OCD) affects approximately 2-3% of the population and is characterized by intrusive, distressing thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to reduce the anxiety caused by those thoughts. While first-line treatments — high-dose SSRIs and Exposure and Response Prevention (ERP) therapy — are effective for many patients, approximately 40-60% of OCD patients do not achieve adequate symptom relief with these standard approaches.
Ketamine has emerged as an area of active research for treatment-resistant OCD, offering the potential for rapid symptom reduction in a condition that typically responds slowly to conventional treatments. Unlike SSRIs, which must be taken at high doses for 8-12 weeks before full OCD benefit is seen, ketamine can reduce OCD symptoms within hours of administration.
While ketamine for OCD is still considered investigational and is not FDA-approved for this indication, a growing number of ketamine clinics offer treatment protocols for OCD patients who have exhausted standard options. The rapid symptom relief provided by ketamine can serve as a "bridge" therapy, providing respite from severe symptoms while other long-term treatments are optimized.
How Ketamine Works for OCD
OCD is associated with dysregulation of glutamate signaling in the cortico-striato-thalamo-cortical (CSTC) circuits — the brain networks that regulate habitual behaviors, decision-making, and error detection. In OCD, these circuits become hyperactive, generating persistent "error signals" that manifest as obsessive thoughts and compulsive urges. Ketamine modulates glutamate neurotransmission in these circuits, potentially normalizing their overactivity and providing rapid relief from obsessive-compulsive symptoms.
By blocking NMDA receptors and enhancing AMPA receptor signaling, ketamine may help "reset" the dysfunctional CSTC loops that drive OCD. This rapid modulation of glutamate is fundamentally different from the slow serotonergic changes produced by SSRIs, which explains why ketamine can produce effects within hours while SSRIs take months to reach full efficacy for OCD.
Clinical Evidence
A pivotal study by Rodriguez et al. (2013), published in the journal Neuropsychopharmacology, demonstrated that a single IV ketamine infusion rapidly reduced OCD symptoms within hours in patients with treatment-resistant OCD. Response rates of approximately 50% have been observed in treatment-resistant cases, with significant reductions on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). However, the effects are typically temporary, lasting 1-2 weeks after a single infusion, which has led researchers to investigate repeated dosing protocols and combination strategies to extend benefits.
Who Is a Candidate?
Appropriate candidates for ketamine therapy for OCD include patients who have failed adequate trials of high-dose SSRIs (the standard first-line pharmacotherapy for OCD requires higher doses than depression treatment), have not achieved sufficient relief from ERP therapy (the gold-standard psychotherapy for OCD), and continue to experience severe OCD symptoms that significantly impair daily functioning. Patients with severe OCD and comorbid depression may be particularly strong candidates, as ketamine addresses both conditions. Patients should have a confirmed OCD diagnosis from a psychiatrist experienced in OCD treatment.
Side Effects to Consider
Side effects of ketamine for OCD treatment are similar to those experienced in depression treatment: dissociation, dizziness, nausea, elevated blood pressure, and sedation. For OCD patients, the dissociative experience may temporarily intensify some obsessive thought patterns during the onset of the infusion, though this typically gives way to symptom relief as the treatment progresses. Side effects generally resolve within 1-2 hours after the infusion. Because OCD treatment with ketamine is still considered investigational, patients should seek treatment from clinicians with specific experience in OCD.
Frequently Asked Questions
Common questions about ketamine therapy for obsessive-compulsive disorder.
Can ketamine cure OCD?
Ketamine is not a cure for OCD, and current evidence suggests that its effects on OCD symptoms are temporary, typically lasting 1–2 weeks after a single infusion based on the pivotal study by Rodriguez et al. (2013) published in Neuropsychopharmacology. However, repeated infusion protocols have shown that benefits can be sustained over longer periods when treatments are administered on an ongoing schedule, and a follow-up study by Rodriguez et al. (2016) in the Journal of Clinical Psychiatry confirmed that repeat-dose ketamine maintained OCD symptom improvement. Ketamine can serve as a valuable bridge therapy to provide rapid relief from severe obsessions and compulsions while other long-term treatments like high-dose SSRIs and Exposure and Response Prevention therapy are being optimized to reach full efficacy. Ongoing research is exploring combination strategies to make ketamine's OCD benefits more durable. Ask your psychiatrist about integrating ketamine with ERP for the most comprehensive treatment approach.
How does ketamine help OCD?
Ketamine helps OCD by modulating glutamate signaling in the cortico-striato-thalamo-cortical (CSTC) circuits, the specific brain networks that are hyperactive in OCD and responsible for generating persistent error signals that manifest as obsessive thoughts and compulsive urges. By blocking NMDA receptors and enhancing AMPA receptor function, ketamine can rapidly reduce the overactivity in these circuits, essentially helping to reset the dysfunctional neural loops. This glutamate-based mechanism is fundamentally different from how SSRIs work, which target serotonin and require 8–12 weeks at high doses to reach full OCD efficacy. The study by Rodriguez et al. (2013) demonstrated that a single IV ketamine infusion reduced symptoms within hours as measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), with approximately 50% of treatment-resistant patients responding. This rapid action makes ketamine particularly useful as a bridge therapy for patients awaiting full SSRI response. Discuss with your OCD-experienced psychiatrist whether ketamine could complement your current treatment plan.
Is ketamine FDA approved for OCD?
No, ketamine is not FDA-approved for OCD. It is used off-label by qualified physicians for treatment-resistant OCD, which is a legal and common practice in medicine — approximately 40–60% of OCD patients do not achieve adequate relief from standard treatments, creating significant demand for alternative approaches. Research is ongoing, with multiple clinical trials currently studying ketamine and related glutamate-modulating drugs for OCD. Since ketamine is off-label for this indication, insurance coverage is unlikely, and patients should expect to pay out of pocket at rates similar to depression treatment — typically $400–$800 per IV infusion. It is important to seek treatment at clinics with clinicians specifically experienced in OCD management, as OCD treatment may require different dosing strategies and more frequent maintenance sessions than depression protocols. Ask potential providers about their experience treating OCD patients with ketamine and whether they coordinate care with an OCD-specialized therapist who can provide concurrent ERP therapy.
How many ketamine treatments are needed for OCD?
A typical initial course involves six ketamine infusions over 2–3 weeks, following a protocol similar to that used for treatment-resistant depression. However, because the OCD-specific effects of ketamine may be more temporary than its antidepressant effects — lasting approximately 1–2 weeks per infusion based on data from Rodriguez et al. (2013) — more frequent maintenance sessions are often needed to sustain benefits. Optimal dosing schedules for OCD are still being actively researched, and treatment plans should be individualized based on your symptom response as measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Some clinics combine ketamine infusions with concurrent Exposure and Response Prevention therapy, taking advantage of the neuroplasticity window ketamine creates to enhance the effectiveness of ERP exercises. Response rates of approximately 50% have been observed in treatment-resistant cases. Work with an OCD-experienced psychiatrist to develop a personalized protocol that integrates ketamine with your broader treatment plan for the most sustained improvement.
References
- Rodriguez CI et al. (2013) Neuropsychopharmacology. Proof-of-concept crossover trial showed a single ketamine infusion produced rapid and significant anti-obsessional effects lasting up to one week. [DOI]
- Rodriguez CI et al. (2016) J Clin Psychiatry. Repeat-dose ketamine maintained OCD symptom improvement, with effects sustained over the dosing period. [DOI]
- Martinotti G et al. (2021) Brain Sci. Review of current literature supported glutamatergic modulation via ketamine as a promising therapeutic approach for treatment-resistant OCD. [DOI]
Treatment Types for OCD
Explore the different ways ketamine therapy can be administered for obsessive-compulsive disorder.
IV Ketamine Infusion
Intravenous delivery. Fastest onset, 60-70% response rate. $400-800/session.
Spravato (Esketamine)
FDA-approved nasal spray. Often insurance-covered. $590-885/session.
IM Injection
Intramuscular injection. Similar efficacy, lower cost. $250-500/session.
KAP (Ketamine-Assisted Psychotherapy)
Combines ketamine with guided psychotherapy. $500-1,500/session.